Glycine receptor antibodies have been identified in a few patients with progressive encephalomyelitis with rigidity and myoclonus (PERM), a highly disabling disorder characterised by rigidity, spasm and brainstem symptomatology. The clinical characteristics of patients with glycine receptor antibodies have not yet been fully described and it is not clear whether GlyR-Abs are pathogenic or just an epiphenomenon. This study examined the clinical features and immunotherapy responses of 45 patients; characterised the GlyR-Ab pathogenicity, subunit specificity and binding to different brain region in vitro, and examined mice injected with GlyR-Abs to model the disease in vivo. Most of the patients were classified as PERM but some patients had symptomatology beyond the classical motor manifestations and there were four patients with tumours (thymomas and lymphomas). GlyR-Ab titres were varied in serum and CSF, but there was intrathecal synthesis in the six patients with suitable samples. Most patients were very disabled but almost all showed excellent responses to immunotherapies. The antibodies were mainly IgG1 and IgG3 subclasses, activated complement on glycine receptor-transfected HEK cells at room temperature, and caused internalisation and lysosomal degradation of the glycine receptors at 37°C. GlyR-Abs bound to rodent spinal cord and brainstem co-localising with monoclonal antibodies to GlyRα1 on the surface of neurons. GlyR-IgG injected intra-peritoneally led to impairment in forced walking ability, sensorimotor function and coordination. Analysis of the brain showed that animals injected with patients' IgG, but not control IgG, had antibodies bound to the brainstem, spinal cord, cerebellum and caudate, co-localising with GlyRα1 monoclonal antibody. Intra-cerebroventricular injection of GlyR-IgG caused an anxiety-like behaviour in mice but no evident motor disturbances. These results provide the first evidence of in vitro and in vivo pathogenicity of the GlyR-Abs, supporting the use of long term immunosuppression in these patients to provide them with a good prognosis.

Cryptococcus neoformans var. grubii est responsable de la majeure partie des infections au Cryptococcus chez les individus infectés au VIH-1. Cryptococcus gattii infecte généralement les personnes immunocompétentes. Afin de comprendre les mécanismes responsables de la susceptibilité différentielle de ces espèces lors de l’infection au VIH-1, nous avons établi et caractérisé un modèle novateur de la cryptococcose chez des souris transgéniques (Tg) CD4C/HIVMutA exprimant des gènes du VIH-1, et qui développent une maladie similaire au SIDA. Les objectifs sont de démontrer une différence significative au niveau de la survie, de la réponse inflammatoire et du recrutement cellulaire pulmonaire en fonction de la présence du transgène et de l’espèce de Cryptococcus inoculée. Des analyses de survie, d’histopathologie et de cytométrie en flux sur les populations cellulaires pulmonaires ont été effectuées. Les souris Tg infectées avec C. neoformans H99 ou C23 ont démontré une survie réduite et une augmentation de la dissémination comparativement aux souris non-Tg, contrairement aux souris Tg infectées au C. gattii R265 ou R272. L’examen histopathologique des poumons de souris Tg infectées au H99 a montré une faible réponse inflammatoire, contrairement aux souris non-Tg. Pour la souche R265, il y avait une très faible réponse inflammatoire chez les deux types de souris. Enfin, l’étude des populations cellulaires du poumon a révélé chez les souris Tg une augmentation des pourcentages de macrophages interstitiels et de cellules polymorphonucléaires, ainsi qu’une diminution des lymphocytes T CD4+ et CD8+, indépendamment de l’infection au Cryptococcus. Ce modèle novateur représente donc un outil très pertinent pour l’étude de l’immunopathogenèse de la cryptococcose dans le contexte du VIH. / Cryptococcus neoformans var. grubii is the most frequent cause of AIDS-associated cyptococcosis worldwide, in sharp contrast to Cryptococcus gattii which usually infects immunocompetent individuals. To understand the mechanisms which cause differential susceptibility to these cryptococcal species in HIV infection, we established and characterized a novel model of cryptococcosis in CD4C/HIVMutA transgenic (Tg) mice expressing HIV-1 gene products and developing an AIDS-like disease. The objectives are to demonstrate significant differences in survival, inflammatory response and lung cell recruitment in Tg mice compared to non-Tg mice when inoculated with different species of Cryptococcus. Tg mice infected with C. neoformans strains H99 or C23 consistently displayed reduced survival and an increase of systemic dissemination compared to non-Tg mice, in contrast with Tg mice infected with C. gattii strains R265 or R272. Histopathologic examination of lungs of Tg mice infected with H99 showed a minimal inflammatory cell response, in contrast with the non-Tg mice infected with H99. In the case of R265, both types of mice failed to induce a strong inflammatory response. Finally, expression of the HIV-1 transgene increased the percentage of pulmonary interstitial macrophages and polymorphonuclear cells, while reducing CD4+ and CD8+ T-lymphocytes, independently of cryptococcal infection. This model therefore provides a powerful new tool to further investigate the immunopathogenesis of cryptococcosis in the specific context of HIV-infection.

L’autisme est un trouble envahissant du développement défini uniquement sur des critères comportementaux et l’âge d’apparition. Le X fragile est une pathologie d’origine monogénique dont 15-25% des patients présente le diagnostique complet de l’autisme et dont de nombreux symptômes chevauchent avec l’autisme. Une souris Fmr1 KO a été créée et validée comme modèle pour le X fragile. A l’instar de la variabilité des phénotypes du X fragile chez l’humain, les données préliminaires montrent que la mutation nulle Fmr1 chez la souris interagit avec l'arrière fond génétique. Les travaux présentés visaient à déterminer les caractéristiques autistiques exprimées par les souris Fmr1 KO, ainsi que l’interaction de la mutation nulle avec le fond génétique (souches C57BL/6J, FVB.129P2tm1Cgr /J et leurs hybrides). Les résultats de ces travaux montrent notamment que les souris Fmr1 KO présentent un évitement initial d’approche sociale, des altérations principalement qualitatives des vocalisations, de l’hyperactivité et une augmentation de l’activité diurne. La mutation interagit avec le fond génétique et les résultats actuels indiquent que les KO de fond FVB.129P2tm1Cgr /J ont le phénotype le plus marqué. / Autism is a pervasive developmental disorder defined by behavioural criteria and age of onset. Fragile X is a disorder due to the silencing of the Fmr1 gene. About 15-25% of Fragile X patients are diagnosed as autistic and many symptoms overlap between the two disorders. A mouse Fmr1 KO was created and validated as a model for Fragile X Syndrome. Preliminary data also show that the null mutation interacts with the genetic background. The work presented in this thesis aimed to determine the autistic features expressed in Fmr1 KO mice, as well as the influence of the genetic background (C57BL/6J and FVB.129P2tm1Cgr/J strains, and their reciprocal hybrids) on the expression of the Fmr1 mutation. Our results show an initial inhibition of social approach in Fmr1 KO mice and a qualitative alteration of ultrasonic vocalizations in isolated pups, as well as an increase in activity, especially during the diurnal period. The Fmr1 mutation interacts with the genetic background and the results indicate that KO on the FVB.129P2tm1Cgr/J background show the most marked phenotype.

DOCTORAL THESIS 2012 POKORNA Abstract We have used a well characterized transplantable transgenic mouse model which mimics human acute promyelocytic leukemia (APL), both in its biological characteristics and its response to conventional therapeutic drugs. The aim of our study was to better characterize the efficacy of the combined treatment and to determine molecular markers of clinical outcome. We established a minimal residual disease monitoring based on the high sensitivity of detection of PML-RAR transcripts by polymerase chain reaction (PCR) technology in APL mice. We showed that oncogene-specific PCR-based assays allow, like in patients, the diagnosis, follow-up and prediction of disease evolution. Furthermore, PCR assay was used to assess various tissues and organs for the presence of PML-RAR-positive cells in minimal residual disease free long-term survivors. As expected, majority of mice had no measurable tissue level of PML-RAR demonstrating the efficacy of immunotherapy. However, tracking the oncogene-positive cells reveals for the first time that extramedullary PML-RAR-positive cell reservoirs such as the brain may persist and be involved in the leukemia relapse. We aimed at investigating the immune responses involved in the anti-leukemic effect of the combined immutherapy. To evaluate the...

A Terapia Fotodinâmica (TFD) caracteriza-se por um conjunto de processos físicos, químicos e biológicos que ocorre após a administração de compostos fotossensibilizantes, que ficam retidos preferencialmente nos tecidos alterados, ao que se segue a irradiação com luz visível, ativando esses fotossensibilizadores (FS) por meio da absorção da luz. Nesta modalidade terapêutica, ocorrem mecanismos de transferência de energia entre o FS e o oxigênio molecular presente nos tecidos, gerando espécies reativas de oxigênio capazes de levar as células à morte. A TFD tem uma de suas principais aplicações no tratamento do câncer de pele, e este trabalho tem por objetivo otimizar tal aplicação utilizando a luz intensa pulsada (LIP) como sistema de irradiação. Na literatura, estudos demonstram a eficiência da aplicação de LIP na área dermatológica e estética na remoção de pelos, tratamento de lesões vasculares, acnes e no fotorejuvenescimento da pele, através de efeitos fotoquímicos e térmicos, mas não há relatos sobre aplicações terapêuticas para o câncer de pele. A aplicação da LIP em TFD leva a diferentes tipos de vantagens destacando-se a possibilidade de diminuição do tempo de tratamento, com consequente redução da dor durante o procedimento. Além disso a possibilidade de aplicação de misturas de FSs que absorvam em diferentes comprimentos de onda, promovendo a ativação simultânea de diferentes bandas de absorção que pode levar a potencialização do efeito da TFD. A ideia da irradiação com LIP é permitir a possibilidade de excitar diferentes bandas do FS simultaneamente, bem como reduzir os níveis de saturação do oxigênio dos tecidos devido a longos períodos de irradiação, minimizando também possíveis efeitos térmicos ocasionados pela irradiação prolongada. Neste trabalho, estudou-se a TFD com um equipamento comercial de LIP (Intense Pulse Light, HKS801) utilizando dois precursores do FS endógeno Protoporfirina (PpIX), 5-ácido aminolevulínico (ALA) e aminolevulinato de metila (M-ALA) e os FSs Photodithazine (PDZ) e Indocianina verde (ICV), em modelo de pele normal de suínos. As diferenças relativas à aplicação tópica de ALA e M-ALA por meio de creme e através da aplicação em sistema de injeção de alta pressão sem agulhas (SAFE INJECT) foram avaliadas. O sistema de injeção também foi utilizado para disponibilização dos FSs na pele. O estudo in vitro mostrou que a LIP interagiu com todos os FSs e levou à multiativação de suas bandas. Com relação aos estudos in vivo observou-se diferentes aspectos do uso da LIP para TFD. A avaliação de fluorescência mostrou que a distribuição por injeção foi mais homogênea, sugerindo a possibilidade de protocolos de TFD menos demorados. A análise termográfica mostrou que não ocorre aquecimento relevante do tecido nas aplicações de LIP em aplicações de TFD no protocolo utilizado. A avaliação histológicas das condições entre 24 e 48 horas permitiu observar as diferentes fases do processo cicatricial em função do tempo decorrido. O estudo possibilitou maior entendimento sobre os efeitos da LIP em tecido biológico, especialmente em associação à TFD. Também foi estabelecido, pela primeira vez, um modelo de protocolo para investigação do uso da LIP em modelo animal para TFD em pele, que pode ser extrapolado em futuros estudos para tratamentos oncológicos e dermatológicos. Consideradas as possibilidades oferecidas e a pronta disponibilidade do dispositivo para irradiação, a TFD com LIP torna-se viável técnica e comercialmente para uso clínico. / Photodynamic Therapy (PDT) is mainly composed of physical, chemical, and biological processes that occur after administration of photosensitizing compounds, which are selectively held in abnormal tissues. After visible light irradiation, those photosensitizers (PS) are activated by light absorption. During treatment, energy transfer mechanisms take place between PS and molecular oxygen that is available in tissues, promoting the generation of reactive oxygen species that bring cells to death. One of this technique´s main applications is skin cancer treatment, and this study aims to optimize such a PDT application by using intense pulsed light (IPL) as irradiation system. Literature shows IPL efficacy on dermatological aesthetic procedures, such as hair removal, treatment of vascular lesion, acne and skin photorejuvenation, promoted by photochemical and thermal effects. However, skin cancer treatment was never reported. Using IPL for PDT may bring advantages such as reducing the treatment sessions, which reduces pain during procedures, and the ability to use PS blends that will absorb in different regions of wavelengths, resulting in simultaneous activation of different absorption bands and improving PDT effect. Shorter irradiation may reduce oxygen depletion due to long irradiation periods, and major thermal effects. In this study, PDT was performed using an IPL commercial device (Intense Pulse Light, HKS801) with the application of two PpIX precursors (ALA and MAL) and the exogenous PS Photodithazine (PDZ) and Indocyanine Green (ICG) on porcine health skin model. Administration of the PS or PpIX precursors were investigated both by vehiculation via cream and by high pressure, needle-free injection (SAFE INJECT). The results obtained in this study showed that the damage induced by PDT using the needle-free injection is more expressive than for cream vehiculation. The in vitro study showed that IPL interacted with all PS and promoted absorption bands multi-activation. The in vivo studies showed different aspects of using IPL for PDT. Fluorescence investigation showed that the distribution by the needle-free injection was more homogeneous, suggesting that shorter PDT protocols are possible. Thermography imaging showed that no relevant heating was observed for IPL applications of PDT during the protocols of choice. Histological analysis of conditions between 24 and 48 hours allowed observing the different stages of the healing process as a function of time. This study provided deeper understanding of IPL effects in biological tissues, and particularly when associated to PDT. In addition, for the first time, an investigation protocol for the use of IPL-PDT in porcine healthy skin was designed, which can be extrapolated for future studies on cancer and skin lesions. Given the possibilities and the prompt availability of the irradiation device, IPL-PDT is readily available technically and commercially for clinical use.

O transtorno do espectro autista atinge uma em cada 150 crianças. Sua etiologia ainda é desconhecida, apesar de fortes evidências de fatores genéticos e recentes achados de interferências ambientais, particularmente a ativação imune materna durante a gestação. Em nossos estudos prévios expusemos ratas Wistar no início da gestação ao lipopolissacarídeo (LPS), que mimetiza uma infecção bacteriana (100 µg/kg, intraperitoneal [i.p.], no dia gestacional [GD] 9,5) e observamos prejuízos no comportamento de brincar da prole masculina. Sabendo que esse teste é classicamente usado para avaliação de modelos animais de autismo e da ligação do autismo com fatores ambientais, propusemos que nosso modelo seria um modelo animal de autismo. Para avaliar essa possibilidade, foi objetivo do presente trabalho estudar se nosso modelo de LPS pré-natal (100 µg/kg, i.p., no GD 9,5) causaria os outros sintomas típicos de autistas: anormalidades na comunicação (avaliado pelo teste da vocalização ultrassônica), comportamentos repetitivos e inflexibilidade cognitiva (teste de alternação espontânea no labirinto em T), ausência de demonstração de medo em situações potencialmente perigosas (estímulo olfativo aversivo do odor de gato) e hiperatividade (atividade geral em campo aberto). Visto que alguns autistas apresentam níveis elevados de citocinas pró-inflamatórias e cortisol, bem como neuroinflamação, foram quantificados os níveis de IL-1β, TNF-α e corticosterona séricos, e estudado os astrócitos e micróglia do estriado e bulbo olfatório. Outro objetivo deste trabalho foi estudar os mecanismos centrais associados ao LPS pré-natal, especialmente o sistema dopaminérgico (expressão gênica e proteica de tirosina hidroxilase e receptores dopaminérgicos D1a e D2) do estriado e bulbo olfatório, baseado nos nossos achados prévios de redução de dopamina nessas regiões cerebrais. Também foram avaliados os níveis séricos de corticosterona, o desempenho reprodutivo e o tecido placentário nas mães expostas ao LPS durante a gestação. Por fim, sabendo que o autismo é mais prevalente em homens do que em mulheres, foram avaliadas também as fêmeas expostas pré-natalmente ao LPS: comportamento de brincar, interação social adulta e níveis séricos de corticosterona. A exposição pré-natal ao LPS prejudicou a comunicação, a cognição, a demonstração de medo em situações potencialmente perigosas, além de induzir comportamentos repetitivos/restritos e elevação dos níveis de IL-1β na prole masculina de ratas; as fêmeas não apresentaram os prejuízos observados nos machos. Esses achados sugerem fortemente que nosso modelo de LPS pré-natal induziu comportamentos do tipo autismo em ratos, corroborando com a hipótese dos fatores ambientais no autismo. Acrescenta de maneira inédita um modelo que mimetiza uma infecção bacteriana no início da gestação como indutor do autismo. Mais ainda, a redução da expressão proteica de tirosina hidroxilase estriatal causada pelo LPS pré-natal inclui a hipoatividade do sistema dopaminérgico estriatal como um possível aspecto para explicar o autismo. A elevação nos níveis de corticosterona, prejuízo no desempenho reprodutivo e danos no tecido placentário das ratas ajudaram no entendimento da gênese dos prejuízos na prole. O estabelecimento do modelo experimental de autismo com o LPS pré-natal significa um passo importante para o entendimento dessa desordem e pode auxiliar também na busca por eventuais tratamentos, baseados nas alterações neuroimunes encontradas. / One child in about 150 children has autism spectrum disorder. Despite strong evidence of genetic factors and recent findings of environmental interferences, particularly maternal immune activation during pregnancy, autism etiology is still unknown. In our previous study, we exposed Wistar rats in the beginning of the gestation to lipopolysaccharide (LPS, 100 µg/kg, intraperitoneally [i.p.], on gestational day [GD] 9.5), which mimics a bacterial infection and observed impairments in the play behavior of male offspring. Knowing that play behavior is classically used to evaluate autism animal models and the link between autism and environmental factors, we proposed that our model would be an autism animal model. To evaluate this possibility, the aim of this study was to know whether our prenatal LPS model (100 µg/kg, i.p., on GD 9.5) causes other autism typical symptoms: communication abnormalities (evaluated by the ultrasonic vocalization test), repetitive behavior and cognitive inflexibility (T-maze spontaneous alternation test), absence of fear demonstration in potentially dangerous situations (aversive exposure to cat odor test) and hyperactivity (open field general activity). Because some autistic patients presents high levels of proinflammatory cytokines and cortisol as well as neuroinflammation, we quantified IL-1β, TNF-α and corticosterone serum levels, and studied astrocytes and microglia of striatum and olfactory bulb. Another objective was to study the central mechanisms associated with prenatal LPS, particularly the dopaminergic system (gene and protein expression of tyrosine hydroxylase and dopamine D1a and D2 receptors) of striatum and olfactory bulb, based on our previous findings of reduced dopamine in these brain regions. We also evaluated the corticosterone serum levels, the reproductive performance and the placental tissue of mothers exposed to LPS during pregnancy. Finally, because autism is more prevalent in men than in women, we also evaluated females prenatally exposed to LPS: play behavior, social interaction and adult corticosterone serum levels. Prenatal LPS exposure impaired communication, cognition, fear demonstration of potentially dangerous situations, induced repetitive/restricted behaviors and elevated IL-1β levels of male offspring; females did not present the impairments observed in males. These findings strongly suggest that our model of prenatal LPS induced autism like behaviors in rats, corroborating the hypothesis of environmental factors in autism. It adds an unprecedented way a model that mimics a bacterial infection in early pregnancy as an inducer of autism. Moreover, the striatal tyrosine hydroxylase protein expression reduction caused by prenatal LPS includes hypoactivity of the striatal dopaminergic system as a possible aspect to explain autism. The increase in the corticosterone levels, impairment of reproductive performance and placental tissue injuries of dams helped in understanding the genesis of the offspring impairments. The importance of establishing an experimental model of autism with prenatal LPS is an extra step to better understand this disorder and may also help in the search for possible treatments, based on the observed neuroimmune changes.

Les Malformations Artérioveineuses sont des lésions vasculaires évolutives. Elles peuvent avoir des conséquences neurologiques lourdes liées au risque hémorragique élevé qui est leur mode de révélation le plus fréquent. Le développement de meilleurs outils d’imagerie a beaucoup amélioré le diagnostic de ces lésions et a permis une meilleure compréhension de leur interaction avec le tissu cérébral. Néanmoins, Leur 4eme dimension et leur évolution restent encore obscures.Par ailleurs, les traitements actuels (embolisation, microchirurgie, chirurgie stéréotaxique) sont associés à des risques de morbidité et mortalité importants.Pour ces raisons, nous avons travaillé sur un traitement potentiel peu invasif: des agents antiangiogéniques. Un modèle porcin simplifié a été élaboré consistant en l’occlusion unilatérale de l’artère carotide primitive et externe par voie endovasculaire. Ce modèle a présenté des preuves d’angiogénèse et des modifications anatomopathologiques proches de celles des MAVc humaines. Le Bevacizumab, un anticorps monoclonal pour le VEGF, a été administré in situ sur ce modèle. Les résultats ont montré que l’agent antiangiogénique altère l’angiogénèse sur les specimens histologiques. L’épaisseur de la paroi des vaissaux a été stabilisée après l’injection de Bevacizumab mais le volume des retia est demeuré identique montrant que le volume dépend de l’angiogénèse mais probablement également du flux / Brain arteriovenous malformations are dynamic, evolving vascular lesions. They present high morbidity rates due to hemorrhagic presentation that is the most frequent symptom at onset and potentially high mortality rates .Up to date imaging techniques has greatly facilitated the diagnosis of these lesions and the better understanding of their relation to adjacent brain tissue. However, it remains still a challenge to define their four dimensional nature and its consequences, a fact that can actually optimize their treatment. Embolization, surgery and stereotactic radiosurgery that are currently used in the treatment of AVMs carry also significant morbi-mortality risks. For this reason, a potential minimally invasive treatment with antiangiogenic agents was tested. A swine model was firstly created using the animal’s rete mirabile and performing an endovascular occlusion of one common and external carotid artery. This simplified model presented evidence of angiogenesis and histologic findings that are also observed in human AVMs compared to a control group. Secondly, Bevacizumab that is a monoclonal antibody to vascular endothelial growth factor, was in situ administered on this model. The results showed that the antiangiogenic agent tampered angiogenesis on histologic samples by stabilizing the wall thickness of the arteries but it did not have any effect on volume that is probably depending on flow and not only on angiogenesis.

O autismo é um transtorno complexo do desenvolvimento caracterizado por inúmeros prejuízos comportamentais, tais como perdas na comunicação, socialização e indução da inflexibilidade cognitiva. A reprodução de modelos experimentais de autismo é bastante importante no estudo desse transtorno. A exposição pré-natal ao VPA reproduz sintomas similares àqueles encontrados na condição humana de autismo. Apesar de o VPA ser considerado um provável teratógeno em humanos, pouco se sabe sobre seus mecanismos de ação, ou até mesmo, como ele é capaz de induzir o autismo. O VPA parece influenciar o metabolismo do zinco durante o período pré-natal, podendo comprometer o desenvolvimento fetal normal. Esse estudo foi dividido em duas partes: (1) reproduzir um modelo de autismo induzido por VPA pré-natal (400 mg/kg no GD 12,5) e (2) avaliar se a administração de zinco pré-natal (2 mg/kg 1h após) previne ou ameniza os prejuízos comportamentais e a expressão de TH-estriatal associados ao autismo causados pela exposição pré-natal ao VPA em ratos. Foram avaliados parâmetros reprodutivos, anormalidades comportamentais na comunicação (vocalização ultrassônica), comportamentos repetitivos e na cognição (labirinto em T) e interação social (comportamento de brincar), além de verificar o sistema dopaminérgico por meio da expressão proteica de TH-estriatal na prole masculina e feminina de ratas. O VPA causou danos reprodutivos, prejuízos na vocalização ultrassônica, comportamento repetitivo/restrito, inflexibilidade cognitiva, comprometimento na socialização com diminuição da brincadeira e redução nos níveis de TH- estriatal na prole masculina. A administração de zinco não foi capaz de impedir os danos reprodutivos causados pelo VPA, porém amenizou a inflexibilidade cognitiva e atenuou a brincadeira social, sem reestabelecer os níveis de TH-estriatal. A prole feminina foi menos afetada que a masculina, apresentando apenas a vocalização ultrassônica alterada. O zinco reestabeleceu esse dano. A redução da TH-estriatal na prole masculina sugere que, possivelmente o fenótipo tipo-autista investigado no presente estudo, esteja relacionado a modificações funcionais no sistema dopaminérgico. / Autism is a complex developmental disorder characterized by numerous behavioral impairments, such as communication, socialization and induction of cognitive inflexibility. Reproduction of experimental models of autism is an important tool in the study of this disorder. Prenatal exposure to VPA reproduces symptoms similar to those found in the human condition of autism. The VPA is known as a potential teratogen in humans and its mechanisms of action is not well understood. VPA appears to influence the zinc metabolism during the prenatal period, compromising normal fetal development. This study was done into two parts: (1st) obtain an autism model induced by prenatal VPA (400 mg/kg 12.5 GD) and (2nd) evaluate whether prenatal administration of zinc (2 mg/kg after 1h) prevents or reverses the behavioral impairments and protein striatal TH-expression associated with autism caused by prenatal exposure to VPA in rats. It was evaluated the reproductive parameters, abnormal behavior in the communication (ultrasonic vocalization test), repetitive behavior and cognitive capacity (T-maze test) and social interaction (play behavior test), and the evaluation of the dopaminergic system by quantification of TH-striatal expression in male and female offspring of rats. The VPA was able to cause reproductive damage, impairment in ultrasonic vocalization, repetitive/restricted behavior and cognitive inflexibility, impairment in socialization with decreased play behavior and reduction in striatal TH levels in male offspring. The zinc administration has not been able to prevent reproductive damage caused by VPA, but ameliorates the cognitive inflexibility and attenuated the social play behavior, without restoring TH-striatal levels. The offspring females were less affected as males, with alterations into ultrasonic vocalization only and zinc reestablished this damage. The reduction in striatal TH-male offspring suggests that the autistic-like phenotype, investigated in this study is, may be is related to functional modifications in the dopaminergic system.

O câncer compreende uma doença multifatorial responsável por altíssimos indíces de mortalidade globalmente. Embora atualmente tenhamos resultados positivos em relação ao tratamento do câncer principalmente voltados à imunoterapia, dados alarmantes ainda são encontrados. Assim, desenvolvemos linhagens tumorais geneticamente modificadas para expressarem ovalbumina (mOVA ou cOVA) e luciferase, a fim de estudarmos as interações do sistema imune com o tumor. Em nossos resultados, a presença da ovalbumina indicou: Alteração no perfil de crescimento tumoral em animais previamente imunizados com OVA e posteriormente desafiados com o tumor, ativação de células TCD8+ citóxicas anti-OVA além de demonstrar também a capacidade imunogênica das linhagens tumorais quando estas são administradas nos animais em estado necrótico. Ao todo, nosso modelo demonstrou que estratégias de vacinação anti-tumorais possuem a capacidade de ativação do sistema imune para na otimização do reconhecimento e resposta anti-tumoral. / Cancer is characterized as a multifactorial disease responsible for many deaths globally. Although nowadays we can find positive perspectives regarding cancers treatment, it is still very common to notice some alarming data. Therefore, our group developed some genetically modified tumoral lineages expressing ovalbumin (mOVA or cOVA) together with luciferase, in order to elucidate the relationship between tumor and the immune system. In our results, the presence of ovalbumin demonstrated: Changes in tumoral growth when animals were previously immunized with OVA and then challenged with our tumoral lineages; TCD8+ lymphocytes anti-OVA activation thus ovalbumin immunogenic potential when lineages were exposed to necrotic death followed by in vivo administration. In summary, our model showed that anti-tumoral vaccinations are indeed capable of promoting immune systems activation and consequently, improving the anti-tumor immunity.

Ziel der vorliegenden Arbeit war anhand eines Tiermodells zu untersuchen, 1. ob eine Dosis-Wirkungsbeziehung zwischen der Keimmenge und der Entstehung einer oralen C. albicans Infektion besteht, 2. welche zelluläre Immunantwort auf definierte inokulierte Keimmengen stattfindet, 3. ob sich die Adhärenz von C. albicans an murine Epithelzellen durch Spaltprodukte von Muzin (Glykopeptide) verhindern läßt. Material und Methode: Immunkompetente Inzuchtmäuse (Balb/c) (n=27) und Mäuse mit kombiniertem B- und T-Zelldefekt (SCID) (n=30) wurden mit Keimmengen von10^4 bis 10^8 C. albicans-Zellen/10 mikrol des Stammes DSM 3454 oral inokuliert. Darüber hinaus wurden Balb/c Mäuse (n=8) mit 10^8 C. albicans-Zellen in Kombination mit Glykopeptiden und SCID Mäuse (n=8) mit 10^5 C. albicans-Zellen mit Glykopeptiden inokuliert. Eine Zungenhälfte wurde histologisch mittels Periodic-Acid-Schiff (PAS) Reaktion auf Invasion von Hyphen untersucht. Die andere Hälfte wurde mittels Immunperoxidase-Technik auf die Verteilung immunkompetenter Zellen (CD4, CD13, ICAM-1, E-Selectin, CD74, CD80, CD86, CD103) im Epithel und subepithelialen Bindegewebe untersucht. Ergebnisse: Eine Woche post inoculationem fanden sich weder bei Balb/c noch bei SCID Mäusen klinische Zeichen einer oralen Candidiasis. Die histologischen Ergebnisse mittels PAS-Methode zeigten jedoch, daß eine Inokulationsmenge von 10^8 C. albicans-Zellen bei Balb/c Mäusen und 10^8 Keime bei SCID Mäusen zu einer Infektion der Zungenmukosa führte. Das Ausmaß der immunologischen Reaktion war abhängig von der Inokulationsdosis sowie vom Immunstatus der Tiere. Die Ergebnisse der Inokulation von 10^8 C. albicans-Zellen zusammen mit Glykopeptiden zeigten bei 2/8 Balb/c Mäusen eine Hypheninvasion in das Zungenepithel. Bei 0/8 SCID Mäusen wurde nach Inokulation von 10^4 C. albicans-Zellen zusammen mit Glykopeptiden eine Hypheninvasion in das Zungenepithel beobachtet. Die immunhistochemischen Ergebnisse zeigten, daß die Reaktionen des Wirtes auf die Gabe der Keim-Glykopeptidlösung denen ohne Inokulation entsprachen. Schlußfolgerung: Obwohl bei den eingesetzten C. albicans-Mengen keine klinisch manifeste orale Candidiasis vorhanden war, fanden sich in beiden Tierstämmen inapparente Infektionen des Zungenepithel (Hypheninvasion), die immunologische Reaktionen der Zungenmukosa auslösten. Da nach Inokulation von C. albicans-Zellen zusammen mit Glykopeptiden weniger häufig Infektionen nachgewiesen werden konnten als bei Inokulation derselben Keimmenge ohne Glykopeptide und Nebenwirkungen dieser antiadhäsiven Wirkstoffe bisher nicht nachgewiesen wurden, wäre der unterstützende Einsatz von Muzinen oder deren Spaltprodukten bei Patienten mit erhöhtem Candidiasisrisiko zu erwägen. / This study applied an animal model to address the following questions: 1. Does a dose/effect relationship exist between C. albicans load and the emergence of an oral C. albicans infection, 2. which cellular immune response takes place following inoculation with defined pathogen loads, 3. is it possible to inhibit C. albicans adhesion to murine epithelium cells through the local application of mucine metabolites (glycopeptides). Material and methods: Immunocompetent inbred mice (Balb/c) (n=27) and mice with combined B- and T-cell defects (SCID) (n=30) were orally inoculated with pathogen loads between 10^4 and 10^8 C. albicans cells/10 microl (strain DSM 3454). Moreover, Balb/c mice (n=8) were inoculated with 10^8 C. albicans cells in combination with glycopeptides; SCID mice (n=8) were inoculated with 10^5 cells, also in combination with glycopeptides. One half of the tongue tissue was histochemically examined with the Periodic Acid Schiff (PAS) Method for displaying the invasion of hyphae. The other half of the tissue was examined by immune peroxidase technique for analysing the distribution of immunocompetent cells (CD4, CD13, ICAM-1, E-Selectin, CD74, CD80, CD86, CD103) in the epithelial layers and subepithelial connective tissue. Results: One week following the inoculation, neither group's tissue showed clinical signs of oral candidiasis. Following histochemical preparation (PAS-Reaction) the tongue mucosa showed signs of infection (hyphae) with the inoculation dose of 10^8 C. albicans cells in the case of Balb/c mice and a load of 10^5 pathogens in the case of SCID mice. The extent of the immunologic reaction depended both on the inoculation dose given to the animals and on their immune status. The results of an inoculation of 10^8 C. albicans cells in combination with glycopeptides showed hyphae invasion of the tongue epithelium in 2/8 Balb/c mice. Following an inoculation of 10^5 pathogens in combination with glycopeptides hyphae invasion could be demonstrated in 0/8 SCID mice. The results of immunohistochemical studies showed that the host's reaction to combined glycopeptide-pathogen-inoculation correspond to the reaction without inoculation. Conclusion: Despite the lack of clinical signs of oral candidiasis in neither group's tissue, non-apparent infections of the tongue epithelium were evident leading to immunologic reactions of the tongue mucosa. Inoculation of C. albicans cells in combination with glycopeptides resulted in decreased infection rate compared to a corresponding inoculation dose without glycopeptides. As no side effects have been documented for the oral application of these antiadhesive agents, their use as complimentary therapy for patients at an increased risk for oral candidiasis should be considered.